Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 12—December 2004

Research

Venezuelan Equine Encephalitis Virus, Southern Mexico

José G. Estrada-Franco*, Roberto Navarro-Lopez†, Jerome E. Freier‡, Dionicio Cordova§, Tamara Clements¶, Abelardo Moncayo*, Wenli Kang*, Carlos Gomez-Hernandez#, Gabriela Rodriguez-Dominguez#, George V. Ludwig¶, and Scott C. Weaver*Comments to Author 
Author affiliations: *University of Texas Medical Branch, Galveston, Texas, USA; †Comision Mexico-Estados Unidos para la Prevencion de la Fiebre Aftosa y Otras Enfermedades Exoticas de los Animales, Mexico, Mexico City, Mexico; ‡U.S. Department of Agriculture, Fort Collins, Colorado, USA; §Instituto Nacional de Investigaciones Forestales Agricolas y Pecuarias (INIFAP) Mexico City, Mexico; ¶U.S. Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland, USA; #Instituto de Salud de la Secretaria de Salud de Chiapas, Tuxtla Gutierrez, Chiapas, Mexico

Main Article

Figure 2

Rates of Venezuelan equine encephalitis virus (VEEV) seropositivity by age group for persons living in the La Encrucijada region. Positive samples had 80% plaque reduction neutralization test (PRNT) titers of >1:20. Numbers on bars indicate the total number of serum specimens tested for each age group.

Figure 2. Rates of Venezuelan equine encephalitis virus (VEEV) seropositivity by age group for persons living in the La Encrucijada region. Positive samples had 80% plaque reduction neutralization test (PRNT) titers of >1:20. Numbers on bars indicate the total number of serum specimens tested for each age group.

Main Article

TOP